AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H1609-H1617, 2004. First published June 10, 2004; doi:10.1152/ajpheart.00146.2004
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/4/H1609    most recent
00146.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cabrales, P.
Right arrow Articles by Intaglietta, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cabrales, P.
Right arrow Articles by Intaglietta, M.

Microvascular PO2 during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93({beta}) in hamster window chamber

Pedro Cabrales,1 Nirmala Devi Kanika,2 Belur N. Manjula,2 Amy G. Tsai,1 Seetharama A. Acharya,2 and Marcos Intaglietta1

1Department of Bioengineering, University of California-San Diego, La Jolla, California 92093; and 2Departments of Medicine and of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, New York 10461

Submitted 17 February 2004 ; accepted in final form 3 June 2004

The oxygen transport capacity of nonhypertensive polyethylene glycol (PEG)-conjugated hemoglobin solutions were investigated in the hamster chamber window model. Microvascular measurements were made to determine oxygen delivery in conditions of extreme hemodilution [hematocrit (Hct) 11%]. Two isovolemic hemodilution steps were performed with a 6% Dextran 70 (70-kDa molecular mass) plasma expander until Hct was 35% of control. Isovolemic blood volume exchange was continued using two surface-modified PEGylated hemoglobins (P5K2, P50 = 8.6, and P10K2, P50 = 8.3; P50 is the hemoglobin PO2 corresponding to its 50% oxygen saturation) until Hct was 11%. P5K2 and P10K2 are PEG-conjugated hemoglobins that maintain most of the hemoglobin allosteric properties and have a cooperativity index of n = 2.2. The effects of these molecular solutions were compared with those obtained in a previous study using MP4, a PEG-modified hemoglobin whose P50 was 5.4 and cooperativity was 1.2 (Tsai et al., Am J Physiol Heart Circ Physiol 285: H1411–H1419, 2003). Tissue oxygen levels were higher after P5K2 (7.0 ± 2.5 mmHg) and P10K2 (6.3 ± 2.3 mmHg) versus MP4 (1.7 ± 0.5 mmHg) or the nonoxygen carrier Dextran 70 (1.3 ± 1.2 mmHg). Microvascular oxygen delivery was higher after P5K2 and P10K2 (2.22 and 2.34 ml O2/dl blood) compared with MP4 (1.41 ml O2/dl blood) or Dextran 70 (0.90 ml O2/dl blood); however, all these values were lower than control (7.42 ml O2/dl blood). The total hemoglobin in blood was similar in all cases; therefore, the improvement in tissue PO2 and oxygen delivery appears to be due to the increased cooperativity of the new molecules.

surface-modified hemoglobin; functional capillary density; oxygen-carrying capacity; blood substitutes; tissue oxygen delivery; hemoglobin cooperativity



Address for reprint requests and other correspondence: P. Cabrales, Univ. of California-San Diego, Dept. of Bioengineering, 0412, 9500 Gilman Dr., La Jolla, CA 92093-0412 (E-mail: pcabrales{at}ucsd.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Cabrales and A. G. Tsai
Plasma viscosity regulates systemic and microvascular perfusion during acute extreme anemic conditions
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2445 - H2452.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Cabrales, J. Martini, M. Intaglietta, and A. G. Tsai
Blood viscosity maintains microvascular conditions during normovolemic anemia independent of blood oxygen-carrying capacity
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H581 - H590.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Cabrales, A. G. Tsai, R. M. Winslow, and M. Intaglietta
Extreme hemodilution with PEG-hemoglobin vs. PEG-albumin
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2392 - H2400.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Cabrales, A. G. Tsai, R. M. Winslow, and M. Intaglietta
Effects of extreme hemodilution with hemoglobin-based O2 carriers on microvascular pressure
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2146 - H2153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Cabrales, A. G. Tsai, and M. Intaglietta
Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemodilution
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1708 - H1716.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Cabrales, H. Sakai, A. G. Tsai, S. Takeoka, E. Tsuchida, and M. Intaglietta
Oxygen transport by low and normal oxygen affinity hemoglobin vesicles in extreme hemodilution
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1885 - H1892.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.